Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
PepGen is empowering nucleic acid therapeutics to go the distance.
Arvinas advances therapies degrading disease-causing proteins for life-threatening diseases, from discovery to commercialization.
SiMa.ai is a developer of machine learning technology to deliver a software-centric platform.
Trevi Therapeutics is a clinical-stage biopharmaceutical company that develops drugs for treating uremic pruritus.
Tectonic Therapeutic is a biotechnology company which focuses on scientific research in biochemistry and molecular pharmacology.
Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.
Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.
Applied Therapeutics uses drug-development approach to target molecules and pathways that has roles in fatal or debilitating diseases.
Beckley Psytech is a biotechnology company developing psychedelic-based medicines for mental health conditions.
Arcellx develops engineered cell-based immunotherapies for the treatment of cancer and other serious diseases.
Cerevel Therapeutics is a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric disorders.
Poseida Therapeutics is a biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.
ConnectRN is a tech-enabled network built to improve clinicians' lives through access to community, opportunity, and support.
MedAvail focuses on the discovery, development, and commercialization of advanced nutrition products.
Aptinyx Inc. is a biopharmaceutical company.
Werewolf Therapeutics operates as an oncology biotherapeutics company.
Calithera Biosciences is a pharmaceutical company developing novel small molecule therapeutics for the treatment of cancer.
Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.
Pyramid Biosciences is a provider of biotechnological services.
Theseus Pharmaceuticals is a technology-based company.
Flame Biosciences is a clinical-stage company focused on therapies for cancer and other inflammatory diseases.
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Prevail Therapeutics is a biotechnology company focused on developing novel gene therapies for patients with Parkinson’s disease.
Engage Therapeutics is a clinical stage pharmaceutical company with a deep-seated passion in epilepsy.
Adage Capital Management has invested in 73 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Adage Capital Management's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 23 different industry categories.
Among tracked funding rounds, Cerevel Therapeutics received $450.0M in a Post Ipo Equity round. Adage Capital Management's total known invested capital is $10.9B.
Adage Capital Management's average investment size is $148.9M across its portfolio of 73 companies.
Recent Adage Capital Management portfolio additions include Pepgen, Arvinas, SiMa.ai, Trevi Therapeutics, Tectonic Therapeutic. These companies were founded in 2020 or later.